Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email

Datar Cancer Genetics touts liquid biopsy data

By LabPulse.com staff writers

February 5, 2020 -- Datar Cancer Genetics is highlighting a study published in the International Journal of Cancer that showed a blood test it developed can detect clusters of circulating cancer cells to help identify early-stage disease.

Lead author Dr. Dadasaheb Akolkar, research director of Datar Cancer Genetics, and colleagues conducted a study that included 16,134 participants, 5,509 of whom had cancer and 10,625 of whom had no symptoms. The blood test identified the prevalence of circulating tumor emboli, which could be a new cancer marker, the group reported (Int J Cancer, November 30, 2019).

The test showed an accuracy of more than 94%, according to the company, with circulating tumor emboli identified in 89.8% of cancer cases and in 3% of asymptomatic patients.

"When clusters of cells break off from an [early-stage] tumor and enter the bloodstream we can ... isolate a few hundred malignant cells from more than 100 million cells, from just 10 [mL] of blood," Akolkar said in a company statement. "While almost all the cancer samples had these cell clusters, they were seen in very few of the samples which were apparently without cancer."

How Grail's blood test stacks up in gastrointestinal cancers
An investigational blood test developed by startup Grail has high sensitivity and specificity across a range of gastrointestinal cancer types, though...
Natera evaluates serial cfDNA blood testing in colon cancer
Cell-free DNA (cfDNA) testing company Natera is launching a study this year of its Signatera blood test in patients with stage II/III colorectal cancer...
PGDx, Mayo Clinic collaborate on blood and tissue cancer tests
Personal Genome Diagnostics (PGDx) and the Mayo Clinic announced they are collaborating on the development of a portfolio of regulated tissue-based and...
Anixa recruits more urology centers for study of prostate cancer blood test
Anixa Biosciences announced that the Urology Centers of Alabama and the Idaho Urologic Institute will join other providers in testing and validating its...
Ovarian cancer blood test could reduce unnecessary surgeries
A blood test for 11 plasma proteins may help judge whether women have ovarian cancer, even in its early stages, potentially helping to avoid surgeries,...

Copyright © 2020 LabPulse.com

Last Updated np 2/5/2020 3:18:22 PM